Airwheel at Canton Fair 2026: Discover AI-Powered Luxury Rideable Electric 20inch Cabin Boarding Travel Smart Carry on Hand Suitcase
Avantor Expands RIM Single-Use Portfolio Across APAC
HKTDC backs new blueprint for Hong Kong’s next chapter
GA-ASI Mojave First UAS To Complete Battlefield Short Field Ops
Critical Minerals Minister Officially Opens GMG’s Gen 2.0 Graphene Manufacturing Plant
Results Support Further Exploration of Therapeutic Potential of Lomecel-B to Slow Cognitive Decline, Improve Quality…
Preliminary safety data suggests lead iNKT agonists, PORT-2 and PORT-3, are well tolerated supporting continued…
Addition of Dr. Beg provides Science 37 with expertise to apply more decentralized clinical trial…
DALLAS, Texas, March 31, 2022 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL)…
SAN DIEGO and TORONTO, March 31, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or…
Funds to support clinical development of INX-315, the company’s lead Cyclin-Dependent Kinase 2 inhibitor Sid…
TORONTO, March 31, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP;…
CAMBRIDGE, Mass., March 31, 2022 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology…
Partners with Award-Winning Director Maya Albanese “Patch and Play” introduces the features of the Twirla…
EB-101 pivotal phase 3 VIITAL™ study in RDEB achieves target enrollment; top-line data expected in…
TORONTO, March 31, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX ‐ XLY) (OTCQX:…
Vilobelimab treatment results in relative reduction in 28-day all-cause mortality of 23.9% compared to placebo…
WARRINGTON, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology…
CHESTERBROOK, Pa., March 31, 2022 (GLOBE NEWSWIRE) — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company…
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva,…
MAINZ, Germany, March 31, 2022 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the…
● Autosomal Dominant Polycystic Kidney Disease – XRx-008 Program IND Filed ● CALGARY, Alberta, March 31,…
— OLINVYK® utilization gaining traction in key target markets Seasoned Biopharma Leader Patricia Drake appointed…
Company to host conference call and webcast today, March 31, 2022, at 8:00 AM EDT…
Expect topline data from cystic fibrosis (CF) Phase 2 expansion treatment arms evaluating combination with…